| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2747.1 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2013.64 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1529.33 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 2728.34 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2077.82 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1504.91 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1740.55 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2671.56 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2921.56 | 99 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1869.36 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2751.15 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2540.92 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2814.19 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1952.57 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2355.13 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2741.56 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2230.18 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2524.38 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3005.55 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2837.18 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2565.45 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2976.81 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2595.54 | 98 |